Instead, most were in moderate-penetrance genes that confer a two- to four-fold increase in cancer risk (eg, ATM and CHEK2) as well as low-penetrance mutations (eg, monoallelic MUTYH and APC I1307K). This evidence concerns the gene MUTYH and cancer.